It holds promise in various disease conditions, particularly in inflammatory bowel disease (IBD) treatment, where it has shown substantial efficacy and safety across multiple administration routes
In order to prevent mitochondrial malfunction and sustain metabolic function/energy generation (ATP), NAD+ supplementation may counterbalance the age-related degradation of NAD+ and its precursor nicotinamide mononucleotide by NADases, particularly CD38.7 NAD+ replenishment, however, appears to support a number of other metabolic pathways via NAD+-dependent enzymes in research involving human and animal models (as well as samples and cell lines) (1,2,3)
outcomes vary by individual, injury type, age, and overall health
When administered correctly, it can speed up recovery, relieve chronic joint pain, and reduce the need for invasive treatments or long-term medications